In transit/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection
- 31 January 2006
- journal article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 42 (2), 159-164
- https://doi.org/10.1016/j.ejca.2005.10.012
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Interim results of the Multicenter Selective Lymphadenectomy Trial (MSLT-I) in clinical stage I melanomaJournal of Clinical Oncology, 2005
- Sentinel lymphonodectomy does not increase the risk of loco-regional cutaneous metastases of malignant melanomasEuropean Journal of Cancer, 2005
- The sentinel node procedure in patients with melanomaEuropean Journal of Surgical Oncology, 2004
- High incidence of in-transit metastases after sentinel node biopsy in patients with melanomaBritish Journal of Surgery, 2004
- Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes – one institution's experienceMelanoma Research, 2003
- The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanomaCancer, 2001
- Sentinel Lymph Node Biopsy in Cutaneous Melanoma: The WHO Melanoma Program ExperienceAnnals of Surgical Oncology, 2000
- Validation of the Accuracy of Intraoperative Lymphatic Mapping and Sentinel Lymphadenectomy for Early-Stage MelanomaAnnals of Surgery, 1999
- Multi-Institutional Melanoma Lymphatic Mapping Experience: The Prognostic Value of Sentinel Lymph Node Status in 612 Stage I or II Melanoma PatientsJournal of Clinical Oncology, 1999
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992